Iontophoresis device and method using a rate-controlling...

A - Human Necessities – 61 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61N 1/30 (2006.01)

Patent

CA 2067820

2067820 9105582 PCTABS00005 An iontophoresis device comprising a drug reservoir containing the drug in ionic form and in communication with the skin, a skin permeation enhancing agent contained in the reservoir or in a second reservoir also in communication with the skin, an electrode (12) in electrical communication with the drug reservoir, another reservoir containing electrolyte and, optionally, skin permeation enhancing agent and drug in communication with the skin at a location separated from the drug reservoir, an electrode in contact with the electrolyte-containing reservoir, a D.C. power source connected to the electrodes and rate controlling membranes (14) interposed between the reservoirs and the skin that are impermeable to drug in the absence of a voltage difference between the electrodes and permeable to the drug in the presence of a voltage difference. The skin permeation enhancing agent eliminates the skin as a rate-controlling element, thus making the rate of drug administration dependent upon the membrane permeability, which in turn is controlled electrically.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Iontophoresis device and method using a rate-controlling... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Iontophoresis device and method using a rate-controlling..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iontophoresis device and method using a rate-controlling... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1603728

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.